Peter Cooper

822 total citations
16 papers, 592 citations indexed

About

Peter Cooper is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Peter Cooper has authored 16 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 9 papers in Internal Medicine and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Peter Cooper's work include Blood Coagulation and Thrombosis Mechanisms (12 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Hemophilia Treatment and Research (8 papers). Peter Cooper is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (12 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Hemophilia Treatment and Research (8 papers). Peter Cooper collaborates with scholars based in United Kingdom, United States and Germany. Peter Cooper's co-authors include Michael Makris, Joost J. van Veen, Alex Gatt, F. E. Preston, Martina E. Daly, K. K. Hampton, I. R. Peake, Nicholas Beauchamp, Annette Bowyer and Steven Kitchen and has published in prestigious journals such as Blood, British Journal of Haematology and Thrombosis and Haemostasis.

In The Last Decade

Peter Cooper

16 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Cooper United Kingdom 12 484 255 137 132 69 16 592
A. Šrámek Netherlands 9 349 0.7× 154 0.6× 157 1.1× 102 0.8× 95 1.4× 14 533
Mae B. Hultin United States 12 392 0.8× 80 0.3× 98 0.7× 85 0.6× 79 1.1× 19 513
Wolfgang Schramm Germany 13 459 0.9× 48 0.2× 59 0.4× 95 0.7× 76 1.1× 36 636
Annette Bowyer United Kingdom 17 642 1.3× 82 0.3× 132 1.0× 146 1.1× 118 1.7× 39 795
Aaron Lubetsky Israel 13 452 0.9× 66 0.3× 103 0.8× 103 0.8× 42 0.6× 26 571
A Derlon France 13 235 0.5× 138 0.5× 104 0.8× 32 0.2× 180 2.6× 28 444
John Sioufi Australia 15 389 0.8× 160 0.6× 177 1.3× 41 0.3× 128 1.9× 20 576
F. McCall United Kingdom 9 603 1.2× 378 1.5× 302 2.2× 81 0.6× 71 1.0× 10 714
Inga Hegemann Switzerland 13 241 0.5× 74 0.3× 53 0.4× 78 0.6× 65 0.9× 26 510
Paul Billoir France 9 100 0.2× 67 0.3× 69 0.5× 44 0.3× 28 0.4× 35 286

Countries citing papers authored by Peter Cooper

Since Specialization
Citations

This map shows the geographic impact of Peter Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Cooper more than expected).

Fields of papers citing papers by Peter Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Cooper. The network helps show where Peter Cooper may publish in the future.

Co-authorship network of co-authors of Peter Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Cooper. A scholar is included among the top collaborators of Peter Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Cooper. Peter Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Cooper, Peter, et al.. (2020). Recommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTH. Journal of Thrombosis and Haemostasis. 18(2). 271–277. 37 indexed citations
2.
Cott, Elizabeth M. Van, Christelle Orlando, Gary Moore, et al.. (2019). Recommendations for clinical laboratory testing for antithrombin deficiency; Communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 18(1). 17–22. 63 indexed citations
3.
Greenfield, Robert S., et al.. (2018). Signal Transduction Peptide of Tissue Factor Phosphorylated at Ser258 and the Unphosphorylated STP in Urine Are Potential Biomarkers for Bladder Cancer. Clinical Genitourinary Cancer. 17(2). e247–e257. 4 indexed citations
4.
Cooper, Peter, Anne Goodeve, & Nicholas Beauchamp. (2012). Quality in Molecular Biology Testing for Inherited Thrombophilia Disorders. Seminars in Thrombosis and Hemostasis. 38(6). 600–612. 14 indexed citations
5.
Gatt, Alex, et al.. (2008). Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro. Thrombosis and Haemostasis. 100(8). 350–355. 65 indexed citations
6.
Veen, Joost J. van, Alex Gatt, Annette Bowyer, et al.. (2008). Calibrated automated thrombin generation and modified thromboelastometry in haemophilia A. Thrombosis Research. 123(6). 895–901. 48 indexed citations
7.
8.
Taha, Mahmoud M., Umang Patel, Stephen B. Wharton, Peter Cooper, & Michael Makris. (2007). Fatal spontaneous thrombosis of a cerebral arteriovenous malformation in a young patient with a rare heterozygousprothrombingene mutation. Journal of Neurosurgery Pediatrics. 106(2). 143–146. 10 indexed citations
9.
Mackie, Ian, Peter Cooper, & Steve Kitchen. (2007). Quality Assurance Issues and Interpretation of Assays. Seminars in Hematology. 44(2). 114–125. 15 indexed citations
10.
Gatt, Alex, et al.. (2006). Reversal of Anticoagulation as Assessed by Thrombin Generation Measurement.. Blood. 108(11). 876–876. 1 indexed citations
11.
Gatt, Alex, et al.. (2006). A Novel Protac®-Modified Thrombin Generation Assay To Identify Individuals at Higher Thrombotic Risk.. Blood. 108(11). 1472–1472. 2 indexed citations
12.
Cooper, Peter, et al.. (2003). Evaluation of the Roche LightCycler. Blood Coagulation & Fibrinolysis. 14(5). 499–503. 12 indexed citations
13.
Jennings, Ian & Peter Cooper. (2003). Screening for thrombophilia: a laboratory perspective. British Journal of Biomedical Science. 60(1). 39–51. 13 indexed citations
14.
15.
Makris, Michael, M.J. Leach, Nick Beauchamp, et al.. (2000). Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S. Blood. 95(6). 1935–1941. 91 indexed citations
16.
Beauchamp, Nicholas, Martina E. Daly, K. K. Hampton, et al.. (1994). High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis. British Journal of Haematology. 88(1). 219–222. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Šrámek Breakdown of academic impact, for papers by Mae B. Hultin Breakdown of academic impact, for papers by Wolfgang Schramm Breakdown of academic impact, for papers by Annette Bowyer Breakdown of academic impact, for papers by Aaron Lubetsky Breakdown of academic impact, for papers by A Derlon Breakdown of academic impact, for papers by John Sioufi Breakdown of academic impact, for papers by F. McCall Breakdown of academic impact, for papers by Inga Hegemann Breakdown of academic impact, for papers by Paul Billoir
Rankless by CCL
2026